Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis

  • 0Department of Geriatrics, Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing, China.

|

|

Summary

This summary is machine-generated.

Machine learning models show strong performance in predicting diabetic kidney disease (DKD) risk for type 2 diabetes mellitus (T2DM) patients. Further research is needed to address data bias and improve model generalizability.

Area Of Science

  • Nephrology
  • Medical Informatics
  • Data Science

Background

  • Machine learning (ML) models are increasingly used to predict diabetic kidney disease (DKD) risk in type 2 diabetes mellitus (T2DM) patients.
  • Variability in ML model performance hinders widespread clinical adoption.
  • A systematic review and meta-analysis were conducted to evaluate ML model performance and applicability for DKD risk prediction.

Purpose Of The Study

  • To systematically review and meta-analyze the performance of ML models for predicting DKD risk in T2DM patients.
  • To assess the clinical applicability of these predictive models.
  • To identify key research gaps in the field.

Main Methods

  • A systematic literature search was performed on PubMed, Embase, Cochrane Library, and Web of Science.
  • Studies published up to April 18, 2024, using ML algorithms for DKD risk prediction in T2DM were included.
  • The primary performance metric was the area under the receiver operating characteristic curve (AUC); risk of bias was assessed using PROBAST.

Main Results

  • 26 studies with 94 ML models were included; 25 studies used internal validation, and 8 used external validation.
  • The pooled AUC was 0.839 (95% CI 0.787-0.890) for internal and 0.830 (95% CI 0.784-0.877) for external validation.
  • Deep learning models achieved the highest pooled AUC (0.863), while random forest models showed the best performance among frequently used models (AUC 0.848).

Conclusions

  • ML models demonstrate high performance in predicting DKD risk in T2DM patients.
  • Challenges remain regarding data bias in model development and validation.
  • Future research should prioritize data transparency, standardization, and multicenter validation for generalizability.